KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2025)

Historic FCF Margin for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 13.53%.

  • Amneal Pharmaceuticals' FCF Margin fell 42400.0% to 13.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.01%, marking a year-over-year decrease of 9300.0%. This contributed to the annual value of 8.7% for FY2024, which is 39300.0% down from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' FCF Margin stood at 13.53%, which was down 42400.0% from 8.42% recorded in Q2 2025.
  • Amneal Pharmaceuticals' 5-year FCF Margin high stood at 27.65% for Q1 2021, and its period low was 23.34% during Q2 2022.
  • For the 5-year period, Amneal Pharmaceuticals' FCF Margin averaged around 7.97%, with its median value being 11.25% (2023).
  • Per our database at Business Quant, Amneal Pharmaceuticals' FCF Margin tumbled by -479000bps in 2021 and then skyrocketed by 261200bps in 2023.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' FCF Margin stood at 8.52% in 2021, then crashed by -167bps to 5.7% in 2022, then surged by 458bps to 20.42% in 2023, then plummeted by -31bps to 14.09% in 2024, then fell by -4bps to 13.53% in 2025.
  • Its last three reported values are 13.53% in Q3 2025, 8.42% for Q2 2025, and 0.83% during Q1 2025.